San Diego, CA -- (SBWire) -- 07/27/2021 --A deadline is coming up on August 9, 2021 in the lawsuit filed for certain investors of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX).
Investors who purchased shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) have certain options and there are strict and short deadlines running. Deadline: August 9, 2021. NASDAQ: ACRX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of purchasers of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) common shares between March 17, 2020 and February 12, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 17, 2020 and February 12, 2021, the defendants made false and/or misleading statements and/or failed to disclose that: AcelRx had deficient disclosure controls and procedures with respect to its marketing of DSUVIA, that as a result, AcelRx had been making false or misleading claims and representations about the risks and efficacy of DSUVIA in certain advertisements and displays, that the foregoing conduct subjected the Company to increased regulatory scrutiny and enforcement, and that as a result, the Company's public statements were materially false and misleading at all relevant times. Those who purchased shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) have certain options and should contact the Shareholders Foundation.
Those who purchased shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
NASDAQ: ACRX Investor Notice: Deadline on August 9, 2021 in Lawsuit Against AcelRx Pharmaceuticals, Inc.
A Deadline is coming up on August 9, 2021 in the lawsuit for certain investors in AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX).